Salbutamol EP impurity A

Salbutamol EP impurity A is a diastereomeric epimer of the parent drug Salbutamol, arising from inversion of configuration at the chiral hydroxyl-bearing carbon. It retains the core structure of 4-(1-hydroxy-2-tert-butylaminoethyl)phenol but exhibits distinct stereochemistry at the C-1 position, leading to altered physicochemical properties. This impurity forms via non-enzymatic racemization during synthesis or storage. Its unique spatial arrangement of the tert-butylamino and hydroxyl groups creates a stereoisomeric profile critical for chromatographic differentiation. Analytically, it serves as an HPLC reference standard for quantifying epimeric impurities in Salbutamol drug substance batches.